COPILOT-HF: Cooperative Program for ImpLementation of Optimal Therapy in Heart Failure

NCT05734690 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

503

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: SGLT2i, beta blocker, ARNI, MRA, MTD
BEHAVIORAL: Education-First

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]
[object Object]